Abstract
About this talk
The recent explosion of biomarker science in Alzheimer’s disease and brain aging has led to novel therapies finally reaching patients. However, the utility of these advancements to diverse populations remains largely unknown due to lack of inclusion of these populations in the science that drove these advancements. Dr. O’Bryant is a global expert in Alzheimer’s disease and brain aging among diverse communities, a renowned leader in AD biomarker science, and the principal investigator of the Health & Aging Brain Study – Health Disparities (HABS-HD). HABS-HD is the most comprehensive study of advanced brain biomarkers across diverse populations ever conducted all within a sociocultural context. In this talk, Dr. O’Bryant will present recent HABS-HD findings examining imaging (MRI and PET), plasma and genetic biomarker across diverse populations and discuss how these population differences offer novel opportunities for precision medicine approaches for treating and preventing Alzheimer’s disease. Lastly, he will provide actionable items for the audience to Own Your Brain Health.
Speaker
About the speaker
